Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARS-II pediatric dilated cardiomyopathy registry
NL-OMON40498Recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of milrinone, enalapril, carvedilol and digoxin in dilated cardiomyopathy (DCM) and heart failure (HF) (2 cohorts), sponsored by Erasmus MC. Primary endpoints: Primary composite clinical endpoint, Clinical and phenotypic measures and 4 more. Started Aug 2014; status: recruiting.
02
Drugs
milrinoneenalaprilcarvediloldigoxin
03
Conditions
dilated cardiomyopathy (DCM)heart failure (HF)
Beyond the preview
Go deeper on NL-OMON40498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40498.